Thrombophilic causes of retinal vascular thrombosis: etiology and treatment outcomes.
Bick
Rodger L
RL
Department of Medicine, University of Texas Southwestern Medical Center, Dallas Thrombosis Hemostasis and Vascular Medicine Clinical Center, Dallas, Texas, 75231, USA. rbick@thrombosis.com
Alfar
Hitaf
H
Goedecke
Chris
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000008:administration & dosage; D019411:Clinical Laboratory Techniques; D000077144:Clopidogrel; D017985:Dalteparin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D012164:Retinal Diseases / Q000188:drug therapy / Q000209:etiology; D012171:Retinal Vessels; D019851:Thrombophilia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin; D017985:Dalteparin